The fluoroquinolones: how long will their utility last?

Area of Science:

• Microbiology
• Infectious Diseases
• Pharmacology

Background:

• Injudicious use of fluoroquinolones contributes to treatment failures, increased morbidity, healthcare costs, and fatalities.
• Fluoroquinolone-resistant bacteria pose a significant threat to the hospital, community, and global microbiological environments.
• Emerging bacterial resistance to fluoroquinolones is directly linked to human and veterinary usage patterns.

Purpose of the Study:

• To highlight the risks associated with fluoroquinolone overuse.
• To discuss the mechanisms and implications of fluoroquinolone resistance.
• To introduce newer fluoroquinolone compounds with enhanced activity against resistant strains.

Main Methods:

• Review of existing literature on fluoroquinolone usage and resistance.
• Analysis of current susceptibility testing methods and breakpoint values.
• Evaluation of the efficacy of novel C-8 methoxy-fluoroquinolone compounds.

Main Results:

• Fluoroquinolone resistance develops stepwise and may evade current detection methods.
• Older fluoroquinolone compounds are less effective against resistant bacterial strains.
• C-8 methoxy-fluoroquinolone compounds demonstrate superior activity against resistant bacteria.

Conclusions:

• Fluoroquinolone resistance is a critical threat to antibiotic efficacy.
• Current susceptibility testing may not detect early-stage resistance.
• Novel fluoroquinolone derivatives offer potential solutions for combating resistant infections.